Correlation between serum VEGF-A and tissue expression of VEGF-A, VEGFR-1, -2 and 3 in patients with intracranial tumours

被引：0
|
作者：
Kumar, R.
Kamdar, D.
Madden, L. [1 ]
Hills, C.
Crooks, D.
Greenman, J. [1 ]
O'Brien, D.
机构：
[1] Univ Hull, Postgrad Med Inst, Kingston Upon Hull HU6 7RX, N Humberside, England
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2005年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：286 / 286
页数：1
相关论文
共 50 条
  • [21] Expression of vascular endothelial growth factor a (VEGF-A), VEGF receptor 1 (VEGFR-1) and VEGFR-2 in clear cell and papillary renal cell carcinoma (RCC): Implications for therapy
    Leppert, JT
    Lam, JS
    Yu, H
    Seligson, DB
    Dong, J
    Horvath, S
    Pantuck, AJ
    Figlin, RA
    Belldegrun, AS
    JOURNAL OF UROLOGY, 2005, 173 (04): : 362 - 362
  • [22] A peptide mimicking the binding sites of VEGF-A and VEGF-B inhibits VEGFR-1/-2 driven angiogenesis, tumor growth and metastasis
    Behelgardi, Maryam Farzaneh
    Zahri, Saber
    Mashayekhi, Farhad
    Mansouri, Kamran
    Asghari, S. Mohsen
    SCIENTIFIC REPORTS, 2018, 8
  • [23] Excess endogenous VEGF-A suppresses laser-induced choroidal neovascularization via VEGFR-1
    Nozaki, M
    Sakurai, E
    Raisler, BJ
    Baffi, JZ
    Shibuya, M
    Ambati, BK
    Ambati, J
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [24] Rapamycin suppresses angiogenesis and lymphangiogenesis in melanoma by downregulating VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 expression
    Wang, Min
    Xu, Yuan
    Wen, Guo-Zhong
    Wang, Qian
    Yuan, Si-Ming
    ONCOTARGETS AND THERAPY, 2019, 12 : 4643 - 4654
  • [25] SOLUBLE LEVELS OF VEGF-A AND VEGFR-2 IN PATIENTS WITH ADVANCED NSCLC
    Sirera, R.
    Sanmartin, E.
    Jantus, E.
    Blasco, A.
    Caballero, C.
    Gallach, S.
    Olmo, P.
    del Pozo, N.
    Bremnes, R. M.
    Camps, C.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S55 - S55
  • [26] Correlation between VEGF-A, biomarker of inflammation and dysglycemia
    Ganz, X.
    Hanefeld, M.
    Appelt, D.
    Pistrosch, F.
    Sandner, D.
    Henkel, E.
    Koehler, C.
    Engelmann, K.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2014, 122 (03)
  • [27] Binding of VEGF-A to canine cancer cells with preferential expression of VEGFR1
    Borgatti, Antonella
    Duckett, Megan
    Spangler, Charles
    Modiano, Jaime F.
    VETERINARY WORLD, 2014, 7 (01) : 1 - 6
  • [28] Expression profiling and significance of VEGF-A, VEGFR2, VEGFR3 and related proteins in endometrial carcinoma
    Wang, Jayson
    Taylor, Alexandra
    Showeil, Rania
    Trivedi, Pritesh
    Horimoto, Yoshiya
    Bagwan, Izhar
    Ewington, Lauren
    Lam, Eric W. -F.
    El-Bahrawy, Mona A.
    CYTOKINE, 2014, 68 (02) : 94 - 100
  • [29] VEGF-A induces its negative regulator, soluble form of VEGFR-1, by modulating its alternative splicing
    Saito, Tetsuya
    Takeda, Norihiko
    Amiya, Eisuke
    Nakao, Tomoko
    Abe, Hajime
    Semba, Hiroaki
    Soma, Katsura
    Koyama, Katsuhiro
    Hosoya, Yumiko
    Imai, Yasushi
    Isagawa, Takayuki
    Watanabe, Masafumi
    Manabe, Ichiro
    Komuro, Issei
    Nagai, Ryozo
    Maemura, Koji
    FEBS LETTERS, 2013, 587 (14) : 2179 - 2185
  • [30] Dysregulation of circulating autoantibodies against VEGF-A, VEGFR-1 and PlGF in preeclampsia - A role in placental and vascular health?
    Moe, Kjartan
    Heidecke, Harald
    Dechend, Ralf
    Staff, Anne Cathrine
    PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, 2017, 10 : 83 - 89
12345